Literature DB >> 19235753

Reciprocal immunohistochemical expression of sodium/iodide symporter and hexokinase I in primary thyroid tumors with synchronous cervical metastasis.

Young Ho Jung1, J Hun Hah, Myung-Whun Sung, Kwang Hyun Kim, Soo Youn Cho, Yoon Kyung Jeon.   

Abstract

OBJECTIVES/HYPOTHESIS: Sodium/iodide symporter (NIS) is a glycoprotein which is related to the concentration of radioiodine in thyroid cancer. Glucose transporter-1 (Glut-1) and hexokinases (HK) are glycoproteins related to glucose metabolism (i.e., uptake and phosphorylation) in various cancers. The aim of this study was to determine the immunohistochemical patterns of expression and mutual relationships between NIS, Glut-1, HK I, and HK II in primary thyroid tumors and synchronous cervical metastatic tumors. STUDY
DESIGN: Retrospective experimental study.
METHODS: Nine cases of follicular carcinomas, sixteen cases of papillary carcinomas, and four cases of anaplastic carcinomas were included. The immunohistochemical staining intensities were categorized (scored) as negative (0), weak (1), positive (2), or strongly positive (3) and dichotomized as a negative/weak (scores 0 or 1) or positive expression (scores 2 or 3).
RESULTS: NIS had a positive expression in good prognostic types of thyroid carcinomas, such as follicular carcinomas, more often, while having a positive expression in poor prognostic types of thyroid carcinomas, such as anaplastic carcinomas (P = .033) less often; HK I had the opposite pattern of expression (P = .033). Primary thyroid tumors and corresponding synchronous cervical metastatic tumors had a similar pattern of expression for NIS, HK I, and HK II. NIS had a reciprocal relationship with HK I as compared to Glut-1 with respect to staining intensity on each primary tumor (P = .040).
CONCLUSION: Reciprocal staining pattern of NIS and HK I on primary tumors is related to the staining pattern of NIS and HK I on synchronous as well as occult cervical metastatic tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19235753     DOI: 10.1002/lary.20073

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Relations Between Pathological Markers and Radioiodine Scan and (18)F-FDG PET/CT Findings in Papillary Thyroid Cancer Patients With Recurrent Cervical Nodal Metastases.

Authors:  Jeong Won Lee; Hye Sook Min; Sang Mi Lee; Hyun Woo Kwon; June-Key Chung
Journal:  Nucl Med Mol Imaging       Date:  2015-02-13

2.  Association between sodium iodide symporter and differentiated Thyroid cancer: a meta-analysis of 9 studies.

Authors:  Rui Zhang; Huanjun Wang; Junyu Zhao; Jinming Yao; Hongxia Shang; Huangao Zhu; Lin Liao; Jianjun Dong
Journal:  Int J Clin Exp Med       Date:  2015-10-15

3.  NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features.

Authors:  Catarina Tavares; Maria João Coelho; Catarina Eloy; Miguel Melo; Adriana Gaspar da Rocha; Ana Pestana; Rui Batista; Luciana Bueno Ferreira; Elisabete Rios; Samia Selmi-Ruby; Bruno Cavadas; Luísa Pereira; Manuel Sobrinho Simões; Paula Soares
Journal:  Endocr Connect       Date:  2018-01       Impact factor: 3.335

4.  Risk factors of malignant fluorodeoxyglucose-avid lymph node on preablation positron emission tomography in patients with papillary thyroid cancer undergoing radioiodine ablation therapy.

Authors:  Sang-Geon Cho; Seong Young Kwon; Jahae Kim; Dong-Hyeok Cho; Myung Hwan Na; Sae-Ryung Kang; Su Woong Yoo; Ho-Chun Song
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

5.  Inhibition of hexokinases holds potential as treatment strategy for rheumatoid arthritis.

Authors:  Guanhua Song; Qiqi Lu; Hua Fan; Xiumei Zhang; Luna Ge; Ruisong Tian; Shiguan Wang; Tingting Feng; Jihong Pan; Jingjing Feng; Yabo Xiao; Xin Yi; Ningxin Ren; Lin Wang
Journal:  Arthritis Res Ther       Date:  2019-04-03       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.